https://wikimd.org/index.php?action=history&feed=atom&title=CimoxatoneCimoxatone - Revision history2026-04-26T20:40:05ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=Cimoxatone&diff=5368749&oldid=prevPrab: CSV import2024-03-06T04:23:29Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Cimoxatone.png|thumb|{{PAGENAME}}]]<br>'''Cimoxatone''' is a [[monoamine oxidase inhibitor]] (MAOI) that was developed in the 1970s for the treatment of [[depression]]. It was never marketed, but has been used in scientific research.<br />
<br />
==Pharmacology==<br />
Cimoxatone acts by inhibiting the action of the enzyme [[monoamine oxidase]], specifically MAO-A. This enzyme is responsible for breaking down monoamine neurotransmitters in the brain, including [[serotonin]], [[norepinephrine]], and [[dopamine]]. By inhibiting this enzyme, Cimoxatone increases the levels of these neurotransmitters in the brain, which can help to alleviate the symptoms of depression.<br />
<br />
==History==<br />
Cimoxatone was developed in the 1970s by the pharmaceutical company [[Upjohn]]. It was one of a number of MAOIs developed during this period, as part of a search for safer and more effective treatments for depression. However, Cimoxatone was never marketed, possibly due to concerns about the safety of MAOIs.<br />
<br />
==Research==<br />
Despite never being marketed, Cimoxatone has been used in scientific research. It has been used as a tool to study the role of monoamine oxidase in the brain, and the effects of its inhibition. It has also been used in studies of depression and other psychiatric disorders.<br />
<br />
==See also==<br />
* [[Monoamine oxidase inhibitor]]<br />
* [[Depression]]<br />
* [[Upjohn]]<br />
<br />
==References==<br />
<references/><br />
<br />
[[Category:Monoamine oxidase inhibitors]]<br />
[[Category:Antidepressants]]<br />
[[Category:Abandoned drugs]]<br />
{{pharmacology-stub}}</div>Prab